Page 20 - Glucose Monitoring Devices

Guidelines for SMBG 15

Table 1.1 Current clinical guidelines and consensus statements for self-monitoring
of blood glucose in type 2 diabetes.dcont’d
Guideline Recommendations
• In people with type 2 diabetes not using insulin,
routine glucose monitoring may be of limited
additional clinical benefit. For some individuals,
glucose monitoring can provide insight into the
impact of diet, physical activity, and medication
management on glucose levels. Glucose
monitoring may also be useful in assessing
hypoglycemia, glucose levels during
intercurrent illness, or discrepancies between
measured A1C and glucose levels when there
is concern an A1C result may not be reliable in
specific individuals. A key consideration is that
performing SMBG alone does not lower blood
glucose levels. To be useful, the information
must be integrated into clinical and self-
management plans.
ADA-EASD Consensus Report b • Regular SMBG may help with self-
management and medication adjustment,
particularly in individuals taking insulin.
• SMBG plans should be individualized. People
with diabetes and the healthcare team should
use the data in an effective and timely manner.
• In people with type 2 diabetes not using insulin,
routine glucose monitoring is of limited
additional clinical benefit while adding burden
and cost. However, for some individuals,
glucose monitoring can provide insight into the
impact of lifestyle and medication management
on blood glucose and symptoms, particularly
when combined with education and support.
International Diabetes Federation • SMBG should only be made available to
Global Guideline for Type 2 Diabetes c people with diabetes when they have the
knowledge, skills, and willingness to use the
information obtained through testing to actively
adjust treatment, enhance understanding of
diabetes, and assess the effectiveness of the
management plan on glycemic control.
• The purpose(s) of performing SMBG and using
SMBG data should be agreed between the
person with diabetes and the healthcare
provider.
• SMBG on an ongoing basis should be available
to those people with diabetes using insulin.
• SMBG should be considered for people using
oral glucose-lowering medications as an
Continued